Last reviewed · How we verify
NCT05715658
Pharmacokinetic Study to Evaluate Dabigatran Etexilate in Elderly Subjects
NA trial testing Dabigatran etexilate capsule in Nonvalvular Atrial Fibrillation in 36 participants. Status unknown.
30 June 2023
Quick facts
| Lead sponsor | Dongyang Liu |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 36 |
| Start date | 15 August 2022 |
| Primary completion | 30 June 2023 |
| Estimated completion | 30 July 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- Dabigatran etexilate capsule
Conditions studied
- Nonvalvular Atrial Fibrillation — all drugs for Nonvalvular Atrial Fibrillation →
- Health, Subjective — all drugs for Health, Subjective →
Sponsor
Dongyang Liu
Who can join
18 and older, any sex, with Nonvalvular Atrial Fibrillation or Health, Subjective. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study intends to collect blood samples of adult healthy subjects, elderly healthy subjects and elderly patients with atrial fibrillation after taking dabigatran etexilate for pharmacokinetics and other studies, aiming to reveal the effect of dabigatran etexilate in Chinese elderly population. Pharmacokinetic profile and biomarker concentration levels; fecal samples were collected for gut microbiota studies to further explore potential mechanisms. The results of the study may provide reference for the precision medicine of dabigatran etexilate and other drugs in the elderly population or the development of new clinical drugs.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05715658
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dabigatran etexilate capsule
Trials testing the same drug.
- NCT02710630 — Bioavailability Study of Five Tablet Formulations of Dabigatran Etexilate Compared to Commercial Capsule Formulation in · Phase 1 · completed
Other recruiting trials for Nonvalvular Atrial Fibrillation
Currently open trials in the same condition.
- NCT07125417 — Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure · Phase 4 · recruiting
Other Dongyang Liu trials
Trials by the same sponsor.
- NCT05894811 — A Study on the Effect of Bariatric Surgery on Glucose Metabolism in Chinese Obese and Type 2 Diabetes Patients · not yet recruiting
- NCT05207852 — Clinical Pharmacology of Dexamethasone in Pregnant Women With Preterm Labor · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05715658 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dongyang Liu
- Last refreshed: 8 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05715658.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing